The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Are we thinking too much into this? Could it just be that the person managing this recruitment has simply logged on and closed positions together, but may have stopped actually acting on applications over past few days/weeks?
Guys, don’t set your expectations for an RNS anytime soon. Have said before Feb/March. Why everyone was so certain on January I do not know. ‘Early 2022’… Anytime in Q1 maybe even Q2.
I want to see results as much as the next person, but patience. Late Feb imo.
Not sure about these 200-300% predictions. I’d back a more conservative prediction of £3.50 close on positive results. No doubt will rise over the following weeks but covid sentiment has mostly gone from the markets, at least until the next variant.
You can almost match half of the covid stocks charts to covid cases in the UK, it’s becoming comical watching them rise and fall as cases do so.
Not sure if this has been posted before…
Negative Interferon Beta recommendations?
https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/interferons/
I think we can all see that the Synairgen team are Bullish based on website/job updates and partnership agreement alone. Didn’t need your Pharma mate to tell us that, however nice to hear.
Good luck everybody, big things to come.
My favourite section of the new US job postings:
‘Address all payer groups including US Governmental purchasing and allocation during Emergency Use Authorization (EUA), transitioning to regular commercial and Governmental purchasing upon Biologic License Application (BLA) approval’.
GET READY FOR THE EUA